Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey B Johnson

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [<sup>177</sup>Lu]Lu-PSMA-617Miguel Muniz, Oliver Sartor, Jacob J Orme, et al.
BJU International|November 30, 2024
In-field prostate cancer recurrence following radical prostatectomy and salvage radiationAustin Martin, Ahmed M Mahmoud, Cameron J Britton, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2025
[<sup>177</sup>Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastasesGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
European Urology Oncology|August 2, 2025
Outcomes for [<sup>177</sup>Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate CancerMiguel Muniz, Oliver Sartor, Jacob J Orme, et al.
Cancer Treatment Reviews|May 4, 2024
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are goingMiguel Muniz, Charles L Loprinzi, Jacob J Orme, et al.
Clinical and Translational Radiation Oncology|April 24, 2026
Outcomes of stereotactic body radiotherapy for supraclavicular lymph node metastasis among patients with metastatic prostate cancerAndres L Frias, Bradley J Stish, Ryan M Phillips, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2021
Accuracy of <sup>18</sup>F-Fluorocholine PET for the Detection of Parathyroid Adenomas: Prospective Single-Center StudyThomas A Hope, Claire E Graves, Jeremie Calais, et al.
Journal of the American College of Radiology : JACR|December 1, 2023
ACR Appropriateness Criteria® Incidentally Detected Indeterminate Pulmonary Nodule, Maria D Martin, Travis S Henry, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 6, 2025
Comparative performance of <sup>99m</sup>Tc-pyrophosphate vs. <sup>99m</sup>Tc-hydroxymethylene diphosphonate for cardiac amyloid radionuclide imagingGregorio Tersalvi, Patricia Carey, Armin Garmany, et al.
Circulation. Cardiovascular Imaging|December 8, 2025
Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour <sup>99m</sup>Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded ComparisonGregorio Tersalvi, Patricia Carey, Armin Garmany, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [<sup>177</sup>Lu]Lu-PSMA-617Miguel Muniz, Oliver Sartor, Jacob J Orme, et al.
BJU International|November 30, 2024
In-field prostate cancer recurrence following radical prostatectomy and salvage radiationAustin Martin, Ahmed M Mahmoud, Cameron J Britton, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2025
[<sup>177</sup>Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastasesGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
European Urology Oncology|August 2, 2025
Outcomes for [<sup>177</sup>Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate CancerMiguel Muniz, Oliver Sartor, Jacob J Orme, et al.
Cancer Treatment Reviews|May 4, 2024
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are goingMiguel Muniz, Charles L Loprinzi, Jacob J Orme, et al.
Clinical and Translational Radiation Oncology|April 24, 2026
Outcomes of stereotactic body radiotherapy for supraclavicular lymph node metastasis among patients with metastatic prostate cancerAndres L Frias, Bradley J Stish, Ryan M Phillips, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2021
Accuracy of <sup>18</sup>F-Fluorocholine PET for the Detection of Parathyroid Adenomas: Prospective Single-Center StudyThomas A Hope, Claire E Graves, Jeremie Calais, et al.
Journal of the American College of Radiology : JACR|December 1, 2023
ACR Appropriateness Criteria® Incidentally Detected Indeterminate Pulmonary Nodule, Maria D Martin, Travis S Henry, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 6, 2025
Comparative performance of <sup>99m</sup>Tc-pyrophosphate vs. <sup>99m</sup>Tc-hydroxymethylene diphosphonate for cardiac amyloid radionuclide imagingGregorio Tersalvi, Patricia Carey, Armin Garmany, et al.
Circulation. Cardiovascular Imaging|December 8, 2025
Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour <sup>99m</sup>Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded ComparisonGregorio Tersalvi, Patricia Carey, Armin Garmany, et al.
Pageof 13